Chemomab Therapeutics Ltd. reports

Company location: Tel Aviv
Fiscal year end: 31 December

Chemomab Therapeutics Ltd. has filed 352 SEC EDGAR filings since 07 Nov 2011

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G
20-F
6-K

SEC filing history

Showing 176-200 of 352 matching filings.

Per page

25

Current page

8

CORRESP

CORRESP filing

Filing date: 26 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

UPLOAD

UPLOAD filing

Filing date: 23 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 21 Apr 2021
Reporting date: 19 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D/A File 005-86953

SC 13D/A

Filing date: 15 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

S-3 File 333-255249

FORM S-3

Filing date: 15 Apr 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K/A File 001-38807

FORM 8-K/A

Filing date: 14 Apr 2021
Reporting date: 15 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-38807

FORM 8-K

Filing date: 05 Apr 2021
Reporting date: 05 Apr 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

D File 021-393952

D filing

Filing date: 30 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13D File 005-86953

SCHEDULE 13D

Filing date: 26 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

3 filing

Filing date: 26 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 26 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-86953

PETER THIEL SCHEDULE 13G

Filing date: 26 Mar 2021
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 25 Mar 2021
Reporting date: 16 Mar 2021
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .